Literature DB >> 15880510

Conserved versus innovative features in animal body organization.

Alessandro Minelli1, Giuseppe Fusco.   

Abstract

The origin of evolutionary novelties is a central topic in evolutionary developmental biology (evo-devo) studies. In any new feature, there is a conserved component that is either structural or related to the underlying genetic control, but it is not always obvious what is really new and what is conserved. Nevertheless, disentangling this blending of old and new features is basic to understanding mechanisms of evolutionary change. The origin of arthropod appendages illustrates the complexity in tracing the origin of evolutionary novelties. At the base of the lineage, the main body axis was already segmented and antero-posteriorly patterned, and the genetic tool kit required to form lateral outgrowths was already available. The novelty was possibly the developmental decision to "read" the available axial information and to exploit it for differentiating segmentally patterned and axially segmented appendages. Some important novelties bridge the gap between what have been traditionally distinguished as systemic and local changes. For example, the origin of the body cavities evolved by several animal groups may have been initiated by simple changes in cell-to-cell adhesive properties. Any possible change in an existing ontogenetic pathway has the potential to generate novelties. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15880510     DOI: 10.1002/jez.b.21044

Source DB:  PubMed          Journal:  J Exp Zool B Mol Dev Evol        ISSN: 1552-5007            Impact factor:   2.656


  2 in total

Review 1.  Genotype-phenotype mapping and the end of the 'genes as blueprint' metaphor.

Authors:  Massimo Pigliucci
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-02-27       Impact factor: 6.237

2.  Homeotic evolution in the mammalia: diversification of therian axial seriation and the morphogenetic basis of human origins.

Authors:  Aaron G Filler
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.